Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy - Wikidata - wikimedia - TriplyDB

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

http://www.wikidata.org/entity/Q24683832

about

Entrapment neuropathy results in different microRNA expression patterns from denervation injury in rats MicroRNAs in cardiomyocyte development MicroRNAs 1, 133, and 206: critical factors of skeletal and cardiac muscle development, function, and disease microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7 Trisomy-21 gene dosage over-expression of miRNAs results in the haploinsufficiency of specific target proteins Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths Diagnostic and prognostic value of circulating microRNAs in heart failure with preserved and reduced ejection fraction Update on the Pathogenic Implications and Clinical Potential of microRNAs in Cardiac Disease Non-Coding RNAs Including miRNAs and lncRNAs in Cardiovascular Biology and Disease Role of microRNAs in the reperfused myocardium towards post-infarct remodelling MicroRNAs in heart failure: Small molecules with major impact Differential expression of microRNAs in different disease states.The miR-19a/b family positively regulates cardiomyocyte hypertrophy by targeting atrogin-1 and MuRF-1 NFATc4 is negatively regulated in miR-133a-mediated cardiomyocyte hypertrophic repression Mapping genetic variants associated with beta-adrenergic responses in inbred mice miR-92a inhibits vascular smooth muscle cell apoptosis: role of the MKK4-JNK pathway MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand NMR characterization of an oligonucleotide model of the miR-21 pre-element Loss of MicroRNA-155 protects the heart from pathological cardiac hypertrophy Repression of miR-142 by p300 and MAPK is required for survival signalling via gp130 during adaptive hypertrophy miR-21 promotes fibrogenic epithelial-to-mesenchymal transition of epicardial mesothelial cells involving Programmed Cell Death 4 and Sprouty-1 Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseases Regulation of cardiac microRNAs by serum response factor Developmental expression and cardiac transcriptional regulation of Myh7b, a third myosin heavy chain in the vertebrate heart mir-17-92 cluster is required for and sufficient to induce cardiomyocyte proliferation in postnatal and adult hearts TGFβ-stimulated microRNA-21 utilizes PTEN to orchestrate AKT/mTORC1 signaling for mesangial cell hypertrophy and matrix expansion Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis GTPase Activating Protein (Sh3 Domain) Binding Protein 1 Regulates the Processing of MicroRNA-1 during Cardiac Hypertrophy.Mechanistic Pathways of Sex Differences in Cardiovascular Disease.Cardiovascular and Cerebrovascular Disease Associated microRNAs Are Dysregulated in Placental Tissues Affected with Gestational Hypertension, Preeclampsia and Intrauterine Growth Restriction.MmPalateMiRNA, an R package compendium illustrating analysis of miRNA microarray data MicroRNA-133a engineered mesenchymal stem cells augment cardiac function and cell survival in the infarct heart Discovering ligands for a microRNA precursor with peptoid microarrays.MicroRNA-133a protects against myocardial fibrosis and modulates electrical repolarization without affecting hypertrophy in pressure-overloaded adult hearts MicroRNA profiling in ischemic injury of the gracilis muscle in rats.Role of specific microRNAs for endothelial function and angiogenesis.microRNAs in heart disease: putative novel therapeutic targets?MicroRNAs add a new dimension to cardiovascular disease

P2860

Q21257177-D78FC712-EEE1-4660-8A9B-4026268EC1F3 Q24596454-F0CF89D3-16E4-468D-9BA5-872B4C1CE2DE Q24608809-B93A7435-B20C-4679-9A13-FC69CCAE92BE Q24615529-FF17A4A5-3A2D-4024-AA21-ABD82A15011D Q24622025-301F4609-6C8E-45A7-8887-DB41BD3E857C Q24623247-50D0ABFC-B90A-4233-8779-CD243831A417 Q24648103-F0888590-F5C9-45D3-9DFC-4BCAF5F78B22 Q24653709-7E1D118E-9433-4FB8-9B3C-EE2FD0D93A96 Q26771125-CBA2D9BE-FF78-4DA4-BB28-CA323352E8A8 Q26801907-4EFEC340-4524-4456-A235-61CB73B8360D Q26999363-5F37A321-14F2-4EAE-ADE4-86393EBA23A0 Q27000076-DE4662C6-27AB-4FD4-AFDA-0BDBBFE8D0E4 Q27024714-75A0EFB2-495D-41B4-930A-C6290D10D3F7 Q27693279-2F2B24A6-C64D-4343-AE8F-8C19EF59D6D0 Q28118639-F3E7D27B-B3AD-4D25-B375-BF59B5AF3444 Q28273795-358E2C5C-41DD-4AE9-BB4E-32AB844232E7 Q28481719-ED066D87-E24D-4ACC-9D61-1BCE0893B5C5 Q28505975-1EC56BCE-4CFA-4D76-9345-222D834620A9 Q28509297-DB8B5B95-D93B-4F9E-BDA6-B9F32AD44E9E Q28543184-AD0C59E8-5C5B-4F01-9590-A0C3412EE20A Q28565486-C873861A-C0E8-4D89-A1A7-00793A921809 Q28571438-02629F10-058B-40A0-A605-7FAAE5B70CA0 Q28576728-7AA5B160-9A59-402A-98CC-DF02F2240EB1 Q28583018-0CD01614-57DB-42CF-90CC-98AA3E11372A Q28586225-2DE985A7-A774-422A-B7C8-A0D517C6495B Q28592397-E5CA0E36-F3C2-489A-B4FD-8974239D2A86 Q28594889-218090D4-93C9-48E5-ACBA-1E912F3A3C5A Q28975741-95777951-BF59-4FE8-8DC8-96DB93CE0072 Q29619873-E247AF9E-96FD-4DF4-8D1B-37F578BBEE47 Q30009059-A68BC02E-8B57-4CCC-8B9B-696735D88640 Q30241924-9705D8AE-89D9-41B1-8A39-6B7779BBFC02 Q30387502-6520E168-0D3C-4F44-8837-BD85C56CC5AB Q30585066-A3D90D41-AC85-4249-9B1D-51FEA582C3CD Q30652787-6BD33450-E38D-4E74-A3B6-55050909E8FE Q33475535-B062CF1A-738C-420B-80E4-3703CBCD61FC Q33580704-C5F6323D-AFF2-4EA7-97C9-E89A848EE046 Q33606298-2597BA6E-D00D-4317-967E-586DEB552602 Q33652945-6984DB4D-0043-4F4F-92BC-640A5DE3BCDC Q33728265-B74ACF2F-3BEB-4592-A4DE-9FD3EEB25636 Q33761132-07CB3FCF-C49F-4B0E-BF6F-1F48E651CEC4

P2860

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

http://www.wikidata.org/entity/Q24683832

description

2007 nî lūn-bûn

@nan

2007 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

name

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@ast

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@en

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@nl

type

label

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@ast

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@en

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@nl

prefLabel

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@ast

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@en

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@nl

P1433

Q24683832-88A26041-566C-4726-91E3-8012714BB594

P1476

Q24683832-BCC8166F-2427-45A9-967E-B76C026E1682

P2093

Q24683832-093479BC-F5CD-45E2-A549-900E84CA7F07

Q24683832-120560E3-F7E9-4E93-8132-45DB82B15FA1

Q24683832-2C118074-5F1F-4E80-B3C2-A0FDE368C81A

Q24683832-399E05EA-2B55-4996-BDE0-D4F771A2E09C

Q24683832-70878E19-0129-4F65-B0F2-659EE99C92A6

Q24683832-A32594FC-00F5-4A18-8FB4-902F4FB9DA2E

Q24683832-A65D6BE8-BD3D-4DFA-8C12-5D07E9C0CBA8

Q24683832-D39D6983-2019-4071-884A-76FDF9A711FB

Q24683832-D4F0F565-FDBC-4796-8896-F755F9C43770

P2860

Q24683832-110749D9-82C3-4D11-AE3B-C726D09D2FC4

Q24683832-126B82C4-AB34-4669-8C0E-A212F7A275C2

Q24683832-221059DC-50A6-4EB6-8AD7-595E60FA645C

Q24683832-2EEB0AA1-3E4A-4127-BB3E-4246DA0D92BC

Q24683832-31E3197C-9738-4F9F-84E4-F64A70F313B0

Q24683832-416F31DE-FEDD-4E10-8E60-0BB799B3C784

Q24683832-474E277D-C3FA-4280-8CAE-84A63B4CFA9E

Q24683832-7E542607-AACA-41AF-9834-7F8FF14E7343

Q24683832-8E9281B4-660B-4640-978C-A89B2C79729A

Q24683832-ABC642C5-7FDA-4D0E-B153-37987F0AC718

P304

Q24683832-0F20E34F-ECF0-43C3-AF9E-1E20D50C6BCA

P31

Q24683832-5C61172C-67FC-420E-B7CB-A9B60A1CAF44

P3181

Q24683832-944B3CE2-8AA0-496C-A8E0-0ED4924D3DB2

P356

Q24683832-843766D7-AF54-48D7-A82C-AB2EDADE7982

P407

Q24683832-4CB1A260-7EE2-4CB6-82D7-713689E2E7DF

P433

Q24683832-2AF6BA74-6688-4169-9C3B-014773C18FC9

P478

Q24683832-815BE483-A784-43B0-8C7C-D8F307B49E51

P577

Q24683832-71DD63E1-D659-41C0-9384-633692B2E93B

P5875

Q24683832-3E1FF324-404E-4FAD-8D9F-B86B047B57F7

P698

Q24683832-0632D020-9798-4F41-BECB-48B5C4E51268

P921

Q24683832-C1C69C9F-211B-4957-8549-22569E2D998F

P932

Q24683832-A1A10157-5612-422A-9579-90952307AFAA

P3181

P356

J.YJMCC.2007.04.004

P1433

Journal of Molecular and Cellular Cardiology

P1476

Expression of microRNAs is dynamically regulated during cardiomyocyte hypertrophy

@en

P2093

Da-Zhi Wang

http://www.w3.org/2001/XMLSchema#string

Hee Young Seok

http://www.w3.org/2001/XMLSchema#string

J Michael Thomson

http://www.w3.org/2001/XMLSchema#string

Jian-Fu Chen

http://www.w3.org/2001/XMLSchema#string

Mariko Tatsuguchi

http://www.w3.org/2001/XMLSchema#string

Martin Newman

http://www.w3.org/2001/XMLSchema#string

Mauricio Rojas

http://www.w3.org/2001/XMLSchema#string

Scott M Hammond

http://www.w3.org/2001/XMLSchema#string

Thomas E Callis

http://www.w3.org/2001/XMLSchema#string

P2860

Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy.

The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation

MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development

Extensive post-transcriptional regulation of microRNAs and its implications for cancer

A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure

Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis

Asymmetry in the assembly of the RNAi enzyme complex

Functional siRNAs and miRNAs exhibit strand bias

MicroRNAs: genomics, biogenesis, mechanism, and function

MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells

P304

1137-41

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1903158

http://www.w3.org/2001/XMLSchema#string

P356

10.1016/J.YJMCC.2007.04.004

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2007-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6332851

http://www.w3.org/2001/XMLSchema#string

P698

17498736

http://www.w3.org/2001/XMLSchema#string

P921

P932

1934409

http://www.w3.org/2001/XMLSchema#string